Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CRR Granted Subpoena For White House/FDA Plan B Communications

This article was originally published in The Tan Sheet

Executive Summary

The Center for Reproductive Rights is allowed to subpoena the White House for documents related to the OTC switch application process for Barr's emergency contraceptive Plan B, CRR said Nov. 8

You may also be interested in...



CRR Summary Judgment Filing Cites FDA’s “Bad Faith” Actions On Plan B

A trial is not needed to settle the Center for Reproductive Rights' suit against FDA over the agency's handling of the Plan B switch, the group states April 2

CRR Summary Judgment Filing Cites FDA’s “Bad Faith” Actions On Plan B

A trial is not needed to settle the Center for Reproductive Rights' suit against FDA over the agency's handling of the Plan B switch, the group states April 2

CRR Summary Judgment Filing Cites FDA’s “Bad Faith” Actions On Plan B

A trial is not needed to settle the Center for Reproductive Rights' suit against FDA over the agency's handling of the Plan B switch, the group states April 2

Related Content

Topics

UsernamePublicRestriction

Register

GB140150

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel